HURA · TuHURA Biosciences, Inc./NV

$2.05 -0.09 (-3.99%) At close · Jul 29

Market Cap

$135.64M

63.68M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. James Bianco	CEO	$544,559	$490,536	—	$2,872,000	—	$80,000	$3,987,095
Dan Dearborn	CFO	$380,643	$163,393	—	$1,288,000	—	—	$1,832,036

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. James Bianco	CEO	$463,734	$623,750	—	$4,900,000	—	$80,000	$6,067,484
Dan Dearborn	CFO	$339,101	$375,000	—	$2,200,000	—	—	$2,914,101

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert E. Hoffman	CEO	$589,600	$178,380	$255,923	$160,460	—	—	$1,184,363
Dennis Brown	Chief Scientific Officer	$329,900	$69,279	$42,177	$96,260	—	—	$537,616
Scott Praill	CFO	$320,467	—	$42,177	$96,260	—	—	$458,903

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Robert E. Hoffman	CEO	$356,619	$181,811	—	$2,622,597	—	—	$3,161,028
Scott Praill	CFO	$312,000	$127,920	—	—	—	—	$439,920
Dennis Brown	Chief Scientific Officer	$206,000	$41,277	—	—	—	—	$247,277

Key facts CIK 1498382 CUSIP 898920103 13F (30d) 17 filings 17 filers Visit website Investor relations